Showing results (251-260 of 606) with videos related to

Sort By:
Pageof 61
Pharmacoeconomics - Open|June 23, 2025
Cost-Effectiveness of the CADScor System in Low-Risk Patients Presenting to the Emergency Department with Chest PainSuzanne J Baron, Serge Korjian, C Michael Gibson, et al.
Pharmacoeconomics - Open|December 18, 2025
Economic Evaluation of NHS England's Type 2 Diabetes Path to Remission Pilot Scheme: Evidence From Real-World Data and Patient Simulation ModellingAdam Martin, Tayamika Zabula, Davide Tebaldi, et al.
Pharmacoeconomics - Open|December 17, 2024
Incorporating Resource Constraints in Health Economic Evaluations: Overview and Methodological ConsiderationsPraveen Thokala, Henrique Duarte, Stuart Wright, et al.
Pharmacoeconomics - Open|December 31, 2024
What Does Pharmaceutical 3D Printing Cost? A Framework and Case Study with Hydrocortisone for Adrenal InsufficiencySejad Ayyoubi, Liesbeth Ruijgrok, Hugo van der Kuy, et al.
Pharmacoeconomics - Open|January 23, 2025
Cost-Utility Analysis of LifeVest® in Post-Myocardial Infarction Patients at Risk of Sudden Cardiac Death in EnglandVasileios Kontogiannis, Farai Goromonzi, Brigitte Both, et al.
Pharmacoeconomics - Open|November 19, 2024
Health Economic Evaluation of Antimicrobial Stewardship, Procalcitonin Testing, and Rapid Blood Culture Identification in Sepsis Care: A 90-Day Model-Based, Cost-Utility AnalysisWendy I Sligl, Charles Yan, Jeff Round, et al.
Pharmacoeconomics - Open|October 29, 2024
Mortality, Clinical Complications, and Healthcare Resource Utilization Associated with Managing Transfusion-Dependent β-Thalassemia and Sickle Cell Disease with Recurrent Vaso-occlusive Crises in ItalyChuka Udeze, Melania Dovizio, Chiara Veronesi, et al.
Pharmacoeconomics - Open|November 15, 2024
Economic Burden of Haemophilia from a Societal Perspective: A Scoping ReviewAmr A El-Sayed, Nancy S Bolous
Pharmacoeconomics - Open|November 12, 2024
From Clinical to Non-clinical Outcomes in the Treatment of HIV: An Economic and Organizational Impact AssessmentLucrezia Ferrario, Barbara Menzaghi, Giuliano Rizzardini, et al.
Pharmacoeconomics - Open|August 6, 2024
Estimation of the Clinical, Economic, and Social Burden of Stage IV Non-Small Cell Lung Cancer in MexicoDenisse Añorve Bailon, Javier Picó-Guzmán, Sergio Cifuentes, et al.
Pageof 61